Dimensional Fund Advisors
CRBP icon

Dimensional Fund Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Dimensional Fund Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Buy
136,602
+59,248
+77% +$499K ﹤0.01% 2794
2025
Q4 		$630K Buy
+77,354
New +$955K ﹤0.01% 2934
2025
Q1 		– Sell
-16,075
Closed -$190K – 3334
2024
Q4 		$190K Hold
16,075
– – ﹤0.01% 3171
2024
Q3 		$332K Hold
16,075
– – ﹤0.01% 3096
2024
Q2 		$727K Hold
16,075
– – ﹤0.01% 2962
2024
Q1 		$631K Sell
16,075
-617
-4% -$15.2K ﹤0.01% 3001
2023
Q4 		$101K Sell
16,692
-12,531
-43% -$67.3K ﹤0.01% 3278
2023
Q3 		$197K Sell
29,223
-2,377
-8% -$16.5K ﹤0.01% 3222
2023
Q2 		$248K Buy
31,600
+17,919
+131% +$161K ﹤0.01% 3200
2023
Q1 		$99.5K Buy
+13,681
New +$59.9K ﹤0.01% 3301
2022
Q1 		– Sell
-1,052
Closed -$19K – 3522
2021
Q4 		$19K Hold
1,052
– – ﹤0.01% 3530
2021
Q3 		$32K Sell
1,052
-1,141
-52% -$45K ﹤0.01% 3489
2021
Q2 		$120K Buy
+2,193
New +$122K ﹤0.01% 3394

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors's CRBP Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Corbus Pharmaceuticals (CRBP) stake by 77% in Q1 2026, buying an estimated $499K and bringing the position to 136,602 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Dimensional Fund Advisors first reported a position in CRBP in Q2 2021 and has held it in 13 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Dimensional Fund Advisors held 136,602 shares of Corbus Pharmaceuticals worth $1.28M as of Q1 2026.
  • Dimensional Fund Advisors bought 59,248 Corbus Pharmaceuticals shares in Q1 2026, an estimated $499K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2794 holding.
  • Dimensional Fund Advisors first reported a position in Corbus Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.